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Coxsackievirus type B3 (CV-B3), an enterovirus associated with the pathogenesis
of several human diseases, subverts, or employs the host intracellular signaling
pathways to support effective viral infection. We have previously demonstrated that
Grb2-associated binding protein 1 (GAB1), a signaling adaptor protein that serves as
a platform for intracellular signaling assembly and transduction, is cleaved upon CV-B3
infection, resulting in a gain-of-pro-viral-function via the modification of GAB1-mediated
ERK1/2 pathway. GAB2 is a mammalian homolog of GAB1. In this study, we aim
to address whether GAB2 plays a synergistic role with GAB1 in the regulation of
CV-B3 replication. Here, we reported that GAB2 is also a target of CV-B3-encoded
viral proteinase. We showed that GAB2 is cleaved at G238 during CV-B3 infection
by viral proteinase 2A, generating two cleaved fragments of GAB2-N1−237 and
GAB2-C238−676. Moreover, knockdown of GAB2 significantly inhibits the synthesis of
viral protein and subsequent viral progeny production, accompanied by reduced levels
of phosphorylated p38, suggesting a pro-viral function for GAB2 linked to p38 activation.
Finally, we examined whether the cleavage of GAB2 can promote viral replication as
observed for GAB1 cleavage. We showed that expression of neither GAB2-N1−237 nor
GAB2-C238−676 results in enhanced viral infectivity, indicating a loss-of-function, rather
than a gain-of-function of GAB2 cleavage in mediating virus replication. Taken together,
our findings in this study suggest a novel host defense machinery through which CV-B3
infection is limited by the cleavage of a pro-viral protein.
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INTRODUCTION
Coxsackievirus serotype B3 (CV-B3) is a non-enveloped, human-pathogenic enterovirus in the
Picornaviridae family (Luo et al., 2010). It encompasses a 7.4 kb single-stranded, positive-sense
RNA genome, and is the most common human pathogen associated with the pathogenesis of
pancreatitis, insulin-dependent diabetes mellitus, myocarditis, and aseptic meningitis. Similar
to other viruses, CV-B3 evolves diverse mechanisms to manipulate the intracellular signaling
pathways to support successful viral infection (Luo et al., 2002; Si et al., 2005; Garmaroudi
et al., 2010). We have previously demonstrated that CV-B3 infection induces activation of the
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mitogen-activated protein kinase (MAPK) signaling pathways
(Luo et al., 2002; Si et al., 2005). Inhibition of such activation
significantly inhibits CV-B3 infection and reduces virus-
mediated pathogenesis (Luo et al., 2002; Si et al., 2005). Recently,
we reported that Grb2-associated binding protein 1 (GAB1,
NCBI:NP_002030.2), a signaling adaptor protein that acts as a
platform for intracellular signaling transduction and assembly,
is cleaved upon CV-B3 infection (Deng et al., 2015). As a
result, generation of the N-terminal fragment of GAB1 further
induces sustained activation of ERK1/2 MAPK and consequent
enhancement of viral replication.
GAB2 (NCBI:NP_536739.1) is a functional homolog of GAB1,
which also belongs to the family of insulin receptor substrate
1-like multi-substrate proteins and serves as a platform for the
assembly of signaling proteins (Holgado-Madruga et al., 1996; Gu
et al., 1998; Bouscary et al., 2001; Lock et al., 2002; Chaudhuri
et al., 2011). Upon activation by receptor tyrosine kinases,
GAB2 undergoes tyrosyl-phosphorylation, creating docking sites
for downstream adaptor proteins that mediate further signal
transduction. As such, GAB2 has been considered as a major
mediator of essential cellular processes, including proliferation,
survival, and differentiation. GAB2 is ubiquitously expressed
in many organs and depletion of GAB2 has been associated
with a severe defect in response to passive allergic challenge
and a defective osteoclast differentiation (Nakaoka and Komuro,
2013). The existence of both GAB1 and GAB2 in a single cell
raises the question whether each GAB protein mediates specific
downstream signaling event upon engagement of different
extracellular stimuli, such as growth factors and cytokines (Meng
et al., 2005). It is observed that hepatocyte growth factor
selectively activates GAB1 in epithelial cells that express both
GAB1 and GAB2, partly due to the presence of the Met-binding
domain in GAB1 but not in GAB2 (Lock et al., 2002), while Bcr-
Abl oncoprotein preferentially utilizes GAB2 as its downstream
signaling components in T cells (Gu et al., 1998). Furthermore,
signal transduction studies demonstrated that GAB1 and GAB2
have non-redundant roles in vascular endothelial growth factor-
mediatedmigration and survival of endothelial cells (Caron et al.,
2009).
In this study, we investigated whether GAB2 plays a
synergistic role with GAB1 in controlling CV-B3 replication.
We showed that GAB2 was also cleaved upon CV-B3 infection.
This cleavage took place at position G238 mediated by virally-
encoded proteinase 2A. We further found that knockdown of
GAB2 led to reduced production of viral protein and decreased
virus titers, suggesting a pro-viral function for GAB2. Moreover,
we demonstrated that expression of the cleavage products of
GAB2 did not further enhance viral replication, indicating
that GAB2 cleavage resulted in its loss-of-function, rather than
gain-of-function in supporting viral replication that represents a
novel host defense mechanism.
METHODS AND MATERIALS
Cell Culture and Viral Infection
HeLa cells purchased from American Type Culture Collection
(Manassas, VA, USA) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum at 37◦C in a humidified incubator with 5% CO2. CV-B3
(Nancy strain) was maintained at −80◦C freezers. Ultraviolet
(UV)-irradiated virus was prepared and viral infection was
performed as previously described (Luo et al., 2002).
Plasmids and siRNAs
Hemagglutinin (HA)-tagged wild-type GAB2 (GAB2WT) was
a generous gift from Dr. Roger Daly at the Monash University
(Melbourne, Australia). The HA-tagged GAB2G238E was
established by replacing the glycine (G) residue at amino acid
238 of wild-type GAB2 with glutamic acid (E). The wild-type
GAB2 was used as a template to generate two truncated forms
of GAB2. The resulting fragments were cloned into a vector
expressing 3×Flag at its N-terminus (3×Flag-GAB2-N1−237 and
3×Flag-GAB2-C238−676). The small interfering RNAs (siRNAs)
against human GAB1 and human GAB2 were purchased from
Dharmacon (Ottawa, ON, Canada).
Transient Transfection and Drug Treatment
Transfection of plasmids and siRNAs was performed according
to manufacturer’s instructions using Lipofectamine R© 2000
(#11668019, Invitrogen, Burlington, ON, Canada) for plasmid
transfection or Oligofectamine R© (#12252-011, Invitrogen,
Burlington, ON, Canada) for siRNA transfection. For drug
treatment, pan-caspase inhibitor zVAD (50 µM, #550377, BD
Biosciences, San Jose, CA, USA) was applied for the blockage of
general caspase activation. SB203580 (50 µM, #S8307, Sigma-
Aldrich, St. Louis, MO, USA) was used for inhibition of p38
activity.
Western Blot Analysis
Cellular proteins were extracted usingmodified oncogene science
lysis buffer (250 mM NaCl, pH 7.2, 50 mM Tris-HCl, 0.1%
NP-40, 2 mM EDTA, and 10% glycerol) supplemented with
protease inhibitors. The concentrations of the protein were
determined by Bradford assay. A total of 20–40 µg of protein per
sample was loaded for sodium dodecyl sulfate-polyacrylamide
gel electrophoresis. Western blotting was performed as described
previously (Shi et al., 2014). Primary antibodies used in this study
were: (1) anti-human GAB2 (#3239, Cell signaling, Beverly, MA,
USA); (2) anti-Flag (sc-807, Santa Cruz, Dallas, TX, USA); (3)
anti-HA (sc-805, Santa Cruz, Dallas, TX, USA); (4) anti-viral
capsid protein VP1 (NCL-ENTERO, Leica biosystems, Concord,
ON, Canada); (5) anti-cleaved caspase-3 (#9661, Cell signaling,
Beverly, MA, USA); (6) anti-phospho-p44/42 MAPK (ERK1/2)
(#4094, Cell signaling, Beverly, MA, USA); (7) anti-phospho-
p38 MAPK (#4511, Cell signaling, Beverly, MA, USA); (8) anti-
phospho-SAPK/JNK (#4668, Cell signaling, Beverly, MA, USA);
(9) anti-β-actin (#2228, Sigma-Aldrich, St. Louis, MO, USA);
and (10) anti-phospho-HSP27 (sc-81498, Santa Cruz, Dallas, TX,
USA).
In Vitro Cleavage Assay
Purified viral proteinase 2A and catalytically inactive 2A were
generous gifts from Dr. Eric Jan at the University of British
Columbia. The assay was performed according to the protocol
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previously described (Deng et al., 2015). The cleaved fragments of
GAB2 were examined by western blotting. CV-B3-infected HeLa
cells were used as a positive control.
Viral Plaque Assay
The virus titers in the supernatant of CV-B3-infected cells were
measured by plaque assay as described previously (Deng et al.,
2015). Briefly, the supernatant was serially diluted and overlaid
on a monolayer of HeLa cells with 90% confluence for 1 h
prior to the replacement of the medium with complete DMEM
containing 0.75% agar. After 3-day incubation, the cells were
fixed with Carnoy’s fixative (75% ethanol and 25% acetic acid)
and then stained with 1% crystal violet. The resulting plaques
were counted and the virus titers were calculated as plaque
forming unit (PFU) per milliliter.
Statistical Analysis
All results presented are representative of at least three
independent experiments. Results are expressed as means ±
standard deviations (SD). Statistical analysis was performed with
unpaired student’s t-test. The p < 0.05 were considered to be
statistically significant.
RESULTS
Proteolytic Process of GAB2 upon CV-B3
Infection
To understand the possible role of GAB2 in CV-B3 infection, we
first examined the protein level of GAB2 upon viral infection. As
shown in Figure 1A, protein level of GAB2 began to decrease
at 5 h and disappeared at 7 h post-infection, accompanied
by the generation of an additional band at around 60 kDa
using an antibody against the C-terminus of GAB2, suggesting
a possible cleavage event. To verify this, a plasmid expressing
C-terminal HA-tagged GAB2 (GAB2-HA) was utilized. HeLa
cells transfected with GAB2-HA were infected with CV-B3 for
indicated hours and protein expression of GAB2 was examined.
We found that, similar to the finding in Figure 1A, an extra
band of exogenous GAB2 was detected at around 60 kDa using
an anti-HA antibody (Figure 1B), indicating that GAB2 is also
cleaved after CV-B3 infection. It is noted that the cleavage
efficiency of exogenously transfected GAB2 is much lower
than that of endogenous GAB2. We have previously reported
that liposome-mediated cDNA transfection inhibits CV-B3
attachment to the cells by disrupting membrane cholesterol
(Wong et al., 2006). Thus, the decreased cleavage efficiency is
likely a result of reduced viral infectivity in transfected cells.
CV-B3 Proteinase 2A-Mediated Cleavage
of GAB2
We then investigated the mechanism leading to GAB2 cleavage.
We first tested whether viral replication is required for
GAB2 cleavage. We utilized UV-irradiated viruses, which are
capable of interacting with viral receptor and subsequent
entering into cells, but unable to replicate. We showed that
GAB2 was not cleaved in cells infected with UV-CV-B3,
suggesting that GAB2 cleavage is dependent on viral replication
(Figure 2A).
CV-B3 encodes two proteinases, 2A and 3C, which not
only process viral polyprotein into individual structural and
nonstructural protein, but also target cellular proteins to either
facilitate infection or provoke host anti-viral machinery (Jurgens
et al., 2006; Zaragoza et al., 2006; Feng et al., 2014). In
vitro cleavage assay was performed to determine whether viral
proteinases contribute to the cleavage of GAB2 upon CV-B3
infection. As shown in Figure 2B, incubation with wild-type 2A
(2AWT) led to the generation of a cleavage band at ∼60 kDa,
corresponding to what was detected during CV-B3 infection.
However, the catalytic mutant of 2A (2Amut) failed to cleave
GAB2, suggesting that cleavage of GAB2 is mediated through
the catalytic activation of 2A. In vitro cleavage assay was also
conducted using purified 3C proteinase. However, no cleavage
products were detected (data not shown).
Furthermore, to rule out the possible role of caspase activation
in GAB2 cleavage, we treated cells with the general caspase
inhibitor, z-VAD. We found that caspase inhibition did not
FIGURE 1 | GAB2 is cleaved upon CV-B3 infection. (A) HeLa cells were inoculated with CV-B3 at an MOI of 10 for indicated time. Western blotting was
conducted to examine protein levels of GAB2 using an antibody that recognizes the C-terminus of GAB2. Viral capsid protein VP1 was probed as an evidence of viral
infection and β-actin was examined as protein loading control. (B) HeLa cells were transiently transfected with a plasmid expressing wild-type GAB2 with an epitope
of HA at its C-terminus for 48 h, followed by CV-B3 infection for various time points as indicated. Western blot analysis was performed for detection of exogenous
GAB2 (using anti-HA antibody), VP1, and β-actin.
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FIGURE 2 | Cleavage of GAB2 is catalyzed by CV-B3-encoded proteinase 2A. (A) HeLa cells were sham-infected or infected with either wild-type (WT) or
ultraviolet (UV)-irradiated CV-B3 at an MOI of 10 for 7 h. Protein levels of GAB2, VP1, and β-actin were detected by western blot analysis. (B) HeLa cells were
transiently transfected with GAB2-hemagglutinin (HA) for 48 h. Fifty micrograms of cell lysates were incubated with 0.4 µg of purified CV-B3 wild-type (2AWT ) or
catalytic mutant (2AMut) of 2A for 18 h. Western blotting was carried out to examine protein expression of GAB2 using an anti-HA antibody. Sham and
CV-B3-infected, GAB2-HA-transfected HeLa cell lysates were loaded as negative and positive control (right two lanes), respectively. (C,D) HeLa cells were sham or
CV-B3-infected in the presence of pan-caspase inhibitor, z-VAD (50 µM), or vehicle (DMSO) for 7 h. Western blotting was performed and protein levels of GAB2, VP1,
and β-actin were examined (C). The inhibition of caspase activation by z-VAD was confirmed by the blockage of caspase-3 cleavage (D).
prevent the cleavage of GAB2 (Figure 2C). The inhibition of
caspase activity by z-VAD was confirmed by the blockage
of caspase-3 cleavage (Figure 2D). Taken together, our results
suggested that the cleavage of GAB2 detected during CV-B3
infection is mediated via the catalytic activity of viral proteinase
2A, independent of the activation of caspase.
Cleavage of GAB2 between H237 and G238
Based on the reported cleavage consensus motif of proteinase
2A (i.e., L/I/MxT/S/Nx//G, // indicates the scissile bond, P4
position—L (leucine), I (isoleucine), or M (methionine), P2
position—T (threonine), S (serine), or N (asparagine), P1’
position is commonly G (glycine), x indicates any amino acid
residues) (Wong et al., 2012), we found one potential cleavage
sequence (234LASHG238) on GAB2. To determine whether GAB2
is cleaved at this site, we performed site-directed mutagenesis
to replace G at position 238 with glutamic acid (E). As shown
in Figure 3A, GAB2G238E mutant was uncleavable upon CV-B3
infection, suggesting that G238 is the cleavage site. Figure 3B
illustrates the functional domains, the cleavage site, and the
resulting cleavage fragments of GAB2 following CV-B3 infection.
Inhibition of Viral Replication and MAPK
Signaling by Knocking Down GAB2
We have previously shown that knockdown of GAB1 inhibits
CV-B3 replication (Deng et al., 2015). Here, we questioned
whether GAB2 plays a similar role in CV-B3 infection. Figure 4
revealed that gene-silencing of GAB2 resulted in significant
decreases in viral protein production (Figures 4A,B) and virus
titers (Figure 4C), accompanied by a large reduction of CV-
B3-induced phosphorylation of JNK and p38 (Figure 4A),
suggesting a pro-viral function for GAB2. The importance of p38
activation in viral replication was further demonstrated using
a selective p38 inhibitor (SB203580). Figure 4D showed that
treatment with SB203580 led to a marked reduction of viral
protein expression. Inhibition of p38 activity by SB203580 was
confirmed by reduced levels of phospho-HSP27, a downstream
target of p38 (Figure 4D). No significant effects of JNK
inhibitor on viral replication were observed (data not shown).
Interestingly, unlike deletion of GAB1 that caused a decrease
in phosphorylated ERK1/2, knockdown of GAB2 had no effect
on virus-mediated ERK1/2 phosphorylation (Figure 4A). We
further examined the impacts of forced expression of exogenous
GAB2 on viral replication. We found that viral protein levels and
viral loads failed to further increase in cells overexpressing GAB2
(data not shown), indicating that the levels of endogenous GAB2
are already saturated for viral replication.
Cleavage of GAB2 does not Further
Increase Viral Replication
We next sought to determine the consequence of GAB2 cleavage
during viral infection. HeLa cells were either transfected with
GAB2WT or non-cleavable GAB2 (GAB2G238E). We showed
that the levels of viral protein (Figures 5A,B) and virus titers
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FIGURE 3 | GAB2 is cleaved between H237 and G238 during CV-B3 infection. (A) HeLa cells were transiently transfected with either GAB2WT-HA or
GAB2G238E-HA for 48 h, followed by CV-B3 infection for 7 h. Cleavage of GAB2 was examined using anti-HA antibody by western blot analysis. Protein levels of
β-actin were examined as loading control. (B) Schematic diagram of different function domains and cleavage site of GAB2.
(Figure 5C) were comparable between cells expressing GAB2WT
and GAB2G238E, suggesting that cleavage of GAB2 had no
direct benefits to virus replication. Moreover, we examined the
influence of overexpression of either GAB2-N or GAB-C on
viral replication. As shown in Figures 5D–F, neither VP1 levels
nor virus titers were significantly altered in cells expressing
GAB2 cleavage fragments compared with empty vector control.
Collectively, our results suggest that cleavage of GAB2 results in
the loss of its function in promoting viral infection, rather than
the gain of a pro-viral activity.
DISCUSSION
GAB2 is a scaffolding/docking protein that transduces cellular
signals from the receptors to the intracellular downstream
molecules. Upon activation by a variety of extracellular stimuli,
such as growth factors and cytokines, GAB2 translocates
from the cytoplasm to the plasma membrane, where it is
tyrosine-phosphorylated by receptor tyrosine kinases and then
recruits several Src-homology-2 (SH2)-containing proteins,
including SH2-containing protein tyrosine phosphatase-2
(SHP2), Phosphatidylinositol 3-kinase (PI3K), and Crk,
subsequently leading to the activation of multiple downstream
signaling pathways (e.g., MAPKs and Akt) that are critical
for cell proliferation, differentiation, apoptosis, and survival
(Holgado-Madruga et al., 1996; Gu et al., 1998; Chaudhuri et al.,
2011).
It has been well-documented that activation of the ERK1/2
MAPK promotes CV-B3 replication (Luo et al., 2002; Opavsky
et al., 2002; Cunningham et al., 2003; Jensen et al., 2013).
Inhibition of this pathway by either chemical inhibitors
or a dominant-negative construct significantly decreases the
production of viral protein and progeny virion (Luo et al.,
2002; Cunningham et al., 2003; Jensen et al., 2013; Opavsky
et al., 2002). We have previously revealed an important role
for GAB1-mediated ERK1/2 activation in CVB3 infection (Deng
et al., 2015). However, in contrast to gene-silencing of GAB1,
in this study we found that knockdown of GAB2 had no effect
on ERK1/2 phosphorylation, suggesting a pro-viral activity for
GAB2 independent of the ERK1/2 pathway. In addition to the
ERK1/2 pathway, it has been previously shown that the p38
MAPK also plays a critical role in CV-B3 infection through
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FIGURE 4 | Knockdown of GAB2 inhibits viral replication and MAPK signaling. (A) HeLa cells were transiently transfected with control siRNA (siCon), GAB1- or
GAB2-targeting siRNA (siGAB1 or siGAB2) as indicated for 48 h, followed by CV-B3 infection at an MOI of 10 for 7 h. Western blotting was performed to examine
protein levels of GAB1, GAB2, VP1, p-ERK1/2, p-p38, p-JNK, and β-actin. (B) Protein levels of VP1 were quantitated by densitometric analysis, normalized to β-actin
(mean ± SD, n = 3). #p < 0.001 compared to siCon. (C) Virus titers in the supernatant collected from the experiments above were measured by plaque assay. The
virus titers are presented as mean ± SD (n = 4). #p < 0.001 compared to siCon. (D) HeLa cells were sham or CV-B3 infected in the presence of p38 inhibitor
(SB203580, 50 µM) or vehicle (DMSO) for 7 h. Western blotting was performed to examine protein levels of p-HSP27, VP1, and β-actin.
facilitating viral spread and propagation (Si et al., 2005; Marchant
et al., 2009; Jensen et al., 2013). The significance of p38 pathway
in viral infection is confirmed in the current study (Figure 4D).
Thus, the pro-viral function of GAB2 is likely executed by
activating the p38 pathway, rather than the ERK1/2 pathway. It is
also postulated that cleavage of GAB2 contributes to an antiviral
mechanism via inhibition of the p38 MAPK activity. In addition,
we speculate that the inability of GAB2 knockdown to block
ERK1/2 phosphorylation is due to a compensatory function of
GAB1 in ERK1/2 activation.
We have previously shown that the N-terminal cleavage
fragment of GAB1 (GAB1-N1−174) further enhances ERK1/2
activation and facilitates viral growth (Deng et al., 2015).
However, this effect was not detected for GAB2-N1−237.
Although GAB1-N1−174 and GAB2-N1−237share a highly
conserved PH domain (∼67% identity), GAB2-N1−237 appears
to contain distinct and additional docking sites, which likely
result in a differential preference for harboring downstream
signaling molecules.
Enteroviruses encode two proteinases, 2A and 3C, whose
primary function is to process the viral polyprotein. In addition,
they also target specific host proteins central for protein
translation, RNA replication/stability, signal transduction, and
the maintenance of normal cellular structure, to facilitate
viral infection (Ventoso et al., 1998; Barco et al., 2000; Li
et al., 2001; Jurgens et al., 2006; Kempf and Barton, 2008).
For example, CV-B3-encoded proteinases have been shown
to cleave host eukaryotic initiation factor 4G (eIF4G) and
poly (A)-binding protein (PABP) to shutoff cap-dependent
host protein synthesis, while allowing cap-independent, IRES
(internal ribosome entry site)-mediated viral mRNA translation
(Lamphear et al., 1993; Kerekatte et al., 1999). It has also been
reported that CV-B3 proteinases disrupt innate immune response
via cleaving melanoma differentiation-associated protein 5 and
mitochondrial antiviral signaling protein, permitting viral escape
from the host immune surveillance (Mukherjee et al., 2011; Feng
et al., 2014). In this study, we demonstrate that GAB2 is cleaved
following CV-B3 infection by viral proteinase 2A and knockdown
of GAB2 results in reduced viral replication, supporting an pro-
viral activity for GAB2. Why does CV-B3 induce the cleavage of
a protein that promotes its infection? We postulate that GAB2
is an innocent bystander of proteinase 2A. It is conceivable that
any proteins comprising a consensus cleavage recognition motif,
such as GAB2, could possibly be targeted by viral proteinases.
Indeed, it has been previously shown that CV-B3 infection
results in the cleavage of inhibitor of κBα (IκBα) to generate a
proteolytic fragment that subsequently limits viral replication,
and thus cleavage of IκBα is regarded as a crucial step for the
host to recognize and respond to the pathogens (Zaragoza et al.,
2006).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 March 2017 | Volume 7 | Article 85
Deng et al. GAB2 Cleavage by Coxsackieviral Proteinase 2A
FIGURE 5 | Cleavage of GAB2 does not further increase viral replication. HeLa cells were transiently transfected with (A) C-terminal HA-tagged GAB2WT or
non-cleavable GAB2 mutant (GAB2G238E ), or (D) empty vector, N-terminal Flag-tagged GAB2-N, or GAB2-C for 24 h, followed by CV-B3 infection for 7 h. Cell lysates
were collected for western blot analysis of protein levels of GAB2WT–HA or GAB2G238E-HA using anti-HA antibody, Flag-GAB2-N, or Flag-GAB2-C using anti-Flag
antibody. (B,E) Protein levels of VP1 in (A) and (D) were quantitated by densitometric analysis, normalized to β-actin (mean ± SD, n = 3). (C,F) The supernatant from
above experiments was harvested for plaque assay, and the virus titers are presented as mean ± SD (n = 3).
To establish a causal relationship between GAB2 cleavage
and viral infection, one could test whether expression of a non-
cleavable GAB2 can enhance viral replication. However, in this
study, we showed that overexpression of a non-cleavable form
of GAB2 (GAB2G238E) failed to further increase viral replication
compared to GAB2WT-transfected cells (Figures 5A–C). This
is likely due to the fact that HeLa cells express high-levels of
endogenous GAB2, obscuring the role of exogenous GAB2 in
viral replication. In addition, as mentioned earlier, a large portion
of the exogenously transfected GAB2WT remains uncleaved
following infection, further attenuating the difference in viral
replication between GAB2WT- and GAB2G238E-transfected cells.
In Figure 5D, we showed that the protein levels of GAB2-N
and GAB2-C were markedly reduced following viral infection.
There are two possible explanations for this observation. First,
CV-B3 infection results in the shutoff of cap-dependent host
protein translation as a result of viral proteinase-mediated
cleavage of eIF4G and PABP as discussed above (Lamphear
et al., 1993; Kerekatte et al., 1999). Thus, upon CV-B3 infection,
a decrease in protein synthesis of transfected GAB2-N and
GAB2-C is expected. Second, at the late stage of viral infection,
cellular proteinases are activated (Carthy et al., 1998), which
further contributes to the reduced expression of GAB2 fragments.
In conclusion, our findings in this study that GAB2 is cleaved
upon CV-B3 infection through the proteolytic activity of virus-
encoded proteinase 2A represent a novel host anti-viral strategy
against CV-B3 infection.
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